Cargando…

Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States

Cystic fibrosis (CF) newborn screening (NBS) was universally adopted in 2009 in the United States. Variations in NBS practices between states may impact the timing of diagnosis and intervention. Quantitative metrics can provide insight into NBS programs (NBSP), but the nuances cannot be elucidated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sontag, Marci K., Miller, Joshua I., McKasson, Sarah, Gaviglio, Amy, Martiniano, Stacey L., West, Rhonda, Vazquez, Marisol, Ren, Clement L., Farrell, Philip M., McColley, Susanna A., Kellar-Guenther, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326751/ https://www.ncbi.nlm.nih.gov/pubmed/35892468 http://dx.doi.org/10.3390/ijns8030038

Ejemplares similares

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2020)

Development of National Newborn Screening Quality Indicators in the United States
por: Yusuf, Careema, et al.
Publicado: (2019)

Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
por: Gaviglio, Amy, et al.
Publicado: (2023)

Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository
por: Sontag, Marci K., et al.
Publicado: (2020)

Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
por: Hale, Kshea, et al.
Publicado: (2020)

Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017
por: Sontag, Marci K., et al.
Publicado: (2020)

Detection of disease‐causing CFTR variants in state newborn screening programs
por: McGarry, Meghan E., et al.
Publicado: (2022)

Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2019)

NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center
por: Ojodu, Jelili, et al.
Publicado: (2017)

Actions in Support of Newborn Screening for Critical Congenital Heart Disease — United States, 2011–2018
por: Glidewell, Jill, et al.
Publicado: (2019)

Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights
por: Ideozu, Justin E., et al.
Publicado: (2019)

Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
por: Ideozu, Justin E., et al.
Publicado: (2019)

2206 Chicago Kids Advisory Board: A novel approach to engaging adolescent students in pediatric clinical research
por: Hebal, Ferdynand, et al.
Publicado: (2018)

Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities
por: Lanzkron, Sophie, et al.
Publicado: (2019)

Genomics and Newborn Screening: Perspectives of Public Health Programs
por: Goldenberg, Aaron J., et al.
Publicado: (2022)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Antibiotic duration and changes in FEV(1) are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
por: Espel, Julia C., et al.
Publicado: (2017)

CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease
por: Grosse, Scott D., et al.
Publicado: (2017)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects — United States, 2011–2014
por: Glidewell, Jill, et al.
Publicado: (2015)

Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance
por: Sontag, Marci K., et al.
Publicado: (2018)

Setting a new standard in cystic fibrosis newborn screening illustrates controversial issues as new data emerge
por: Farrell, Philip M.
Publicado: (2020)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Newborn screening for neurodevelopmental diseases: Are we there yet?
por: Chung, Wendy K., et al.
Publicado: (2022)

COVID-19 Pandemic-Related Impacts on Newborn Screening Public Health Surveillance
por: Singh, Sikha, et al.
Publicado: (2022)

A Newborn Screening Education Best Practices Framework: Development and Adoption
por: Evans, Adrianna, et al.
Publicado: (2019)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Two Years of Newborn Screening for Cystic Fibrosis in North Macedonia: First Experience
por: Fustik, S, et al.
Publicado: (2021)

Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity
por: McKasson, Marilyn, et al.
Publicado: (2016)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
por: Sherman, Victoria, et al.
Publicado: (2020)

Factors affecting the growth of infants diagnosed with cystic fibrosis by newborn screening
por: Patterson, K. D., et al.
Publicado: (2019)

Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
por: Thia, Lena P, et al.
Publicado: (2014)

Common Challenges and Identified Solutions for State Newborn Screening Programs during COVID-19 Pandemic
por: Simon, Dylan, et al.
Publicado: (2022)

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR
por: Rayment, Jonathan H., et al.
Publicado: (2022)

Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_433hnev1l4t6hl0j4lnkqmavvf